Does rosuvastatin offer therapeutic potential in autoimmune thyroiditis in nonobese diabetic mice?

Mori, Kouki; Nakagawa, Yoshinori; Hoshikawa, Saeko; Ozaki, Hiroshi; Ito, Sadayoshi; Yoshida, Katsumi

Mori, Kouki; Nakagawa, Yoshinori; Hoshikawa, Saeko; Ozaki, Hiroshi; Ito, Sadayoshi; Yoshida, Katsumi.

Clin Immunol ; 130(3): 375-7, 2009 Mar.

Article in En | MEDLINE | ID: mdl-19019736

Subject(s)

Fluorobenzenes/pharmacology; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology; Pyrimidines/pharmacology; Sulfonamides/pharmacology; Thyroiditis, Autoimmune; Animals; Antibodies/blood; Fluorobenzenes/therapeutic use; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Mice; Mice, Inbred NOD; Pyrimidines/therapeutic use; Rosuvastatin Calcium; Sodium Iodide/pharmacology; Spleen/cytology; Spleen/drug effects; Sulfonamides/therapeutic use; Thyroglobulin/pharmacology; Thyroiditis, Autoimmune/chemically induced; Thyroiditis, Autoimmune/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrimidines / Sulfonamides / Thyroiditis, Autoimmune / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Fluorobenzenes Limits: Animals / Humans Language: En Year: 2009 Type: Article

Fulltext

XML

PubMed Links

Search on Google